SYNTEX CARDENE (NICARDIPINE) LABELING SHOULD ADDRESS LARGE PEAK/TROUGH DIFFERENCES, COMMITTEE SAYS; CARDENE IS APPROVABLE FOR HYPERTENSION -- FDA